SHR2285

N/A

Report date: 2025/11/16 20:00:06
NME

Base Information

Drug NameSHR2285
Drug Alias NameSHR-2285
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFactor XIa inhibitors
TargetsCoagulation factor XI
Therapy Area/IndicationsThrombosisVenous ThromboembolismThromboembolism +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesAtridia Pty LtdJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesShanghai Hengrui Pharmaceutical Co Ltd
Active IndicationsThrombosisThromboembolism
Inactive IndicationsVenous ThromboembolismEmbolism

Other Information

ATC CodeN/A
Related LinksN/A